Document is current
Any future updates will be listed below
-
Authors
Ward, Leanne M. https://orcid.org/0000-0003-1557-9185
-
Funding
Funding for this research was provided by:
Canadian Institutes of Health Research (FRN 64285)
University of Ottawa Tier 1 and Tier 2 Research Chair Award (N/A)
Children's Hospital of Eastern Ontario Departments of Pediatrics and Surgery (N/A)
Children's Hospital of Eastern Ontario Research Institute (N/A)
- License Information
-
More Information
Article History
Accepted: 12 February 2021
First Online: 10 July 2021
Declarations
:
: Dr. Ward has participated in clinical trials with ReveraGen BioPharma, PTC Therapeutics, Catabasis Pharmaceuticals, Novartis, and Amgen. Dr. Ward has also received consulting fees from PTC Therapeutics, Novartis and Amgen, with funds to the Children’s Hospital of Eastern Ontario Research Institute.
: This article does not contain any original studies with human or animal subjects performed by the author.
